Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a global leader in healthcare analytics and cla...
Citigroup analyst Daniel Grosslight upgrades Claritev (NYSE:CTEV) from Neutral to Buy and raises the price target from $55 t...
Citigroup analyst Daniel Grosslight upgrades Claritev (NYSE:CTEV) from Neutral to Buy and announces $55 price target.
As of October 15, 2025, Claritev Corporation (the "Company") has successfully renewed contracts with its ten largest cl...
Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a technology, data and insights company focused...
Piper Sandler analyst Jessica Tassan maintains Claritev (NYSE:CTEV) with a Overweight and raises the price target from $44 t...
– SEC Filing
